Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma

Saved in:
Bibliographic Details
Published inBone marrow transplantation (Basingstoke) Vol. 56; no. 9; pp. 2280 - 2283
Main Authors Derenzini, Enrico, Tabanelli, Valentina, Sammassimo, Simona, Mazzara, Saveria, Motta, Giovanna, Melle, Federica, Vanazzi, Anna, Calleri, Angelica, Fiori, Stefano, Finazzi, Maria Chiara, Barbanti, Maria Chiara, Ramadan, Safaa, Gandini, Sara, Pastano, Rocco, Rambaldi, Alessandro, Pileri, Stefano, Tarella, Corrado
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.09.2021
Nature Publishing Group
Subjects
13/51
38/39
631/67/327
692/308/575
Cancer
Care and treatment
Cell Biology
Correspondence
Health aspects
Hematology
Hematopoietic Stem Cell Transplantation
Homografts
Humans
Immune checkpoint
Immune response
Internal Medicine
Lymphoma
Lymphoma - therapy
Lymphomas
Medicine
Medicine & Public Health
Neoplasm Recurrence, Local
Patient outcomes
Prognosis
Public Health
Relapse
Stem Cell Transplantation
Stem Cells
Transplantation
Italy
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0268-3369
1476-5365
DOI:10.1038/s41409-021-01320-y